ATAAY yields 1.12% · JNJ yields 2.13%● Live data
📍 JNJ pulled ahead of the other in Year 5
Combined, ATAAY + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ATAAY + JNJ for your $10,000?
Atacadão S.A. engages in the wholesale and retail of food, clothing, appliances, electronics, and other products in Brazil. The company operates through Retail, Atacadão, and Financial Solutions segments. The company offers alcoholic and non-alcoholic beverages; chocolate and cocoa powders, sugar and sweeteners, baby foods, rice, oats and cereals, cookies, toasts and snacks, coffee, teas, canned and uncanned products, sweets and deserts, flour, bean, yeast, grains and seed, pasta and sauces, mixture for bakery and confectionery, oils, fats and lard, soups and creams, and seasonings and condiments; and bathroom, kitchen, pool, clothing, and general cleaning products. It also provides personal hygiene and perfumery products; cold and diary products; meat, poultry, and fish products; packaging and disposables; frozen products; stationery and office products; and food baskets. The company offers its products through a chain of wholesale self-service and wholesale delivery stores, hypermarkets, supermarkets, convenience stores, gas stations, pharmacies, and e-commerce under the Carrefour and Atacadão brands. As of December 2020, it operated 721 stores. In addition, the company also credit cards and consumer finance, and other products, such as insurance policies. Atacadão S.A. is based in São Paulo, Brazil.
Full ATAAY Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.